Turku Bioscience
Private Company
Total funding raised: $2M
Overview
Turku Bioscience is a long-established, university-hosted core facility and research centre that provides essential technological infrastructure and expertise in proteomics and genomics to over 200 researchers. Its business model is service-based, supporting both academic and potentially external research through its 11 core facilities while also conducting its own discovery research through 28 affiliated groups. The centre is a key node in the Finnish and European life science ecosystem, driving high-impact publications and fostering collaboration, but its financial model is likely dependent on institutional funding, grants, and user fees rather than product commercialization.
Technology Platform
A suite of 11 shared core facilities providing advanced technologies and expert support in areas including functional genomics, advanced imaging, proteomics, and protein structure/chemistry. It is an integrated infrastructure platform for omics and imaging research.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes with other academic core facilities and non-profit research institutes across Europe for talent, grants, and service contracts. Also faces competition from large, global CROs that offer similar omics services but may lack the deep collaborative academic environment Turku Bioscience provides.